Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
The One Lambda NGS hybrid capture assay utilizes a probe-based design to optimize read balance and uniformity, potentially preventing allele dropout for quality results.
Hybrid capture next-generation sequencing (NGS) is a targeted sequencing technique used to selectively enrich and sequence specific regions of the genome. It combines hybrid capture for target enrichment with NGS for sequencing, enabling detailed analysis of selected genomic regions.
Our simple workflow, product design and comprehensive gene coverage can potentially reduce ambiguity, provide balanced reads and reduce turnaround and hands on time.
Analysis using TypeStream Visual NGS Analysis Software delivers rapid, automated analysis while supporting genotyping and detection of gene copy number values across HLA and non-HLA genes.
Unique dual indexing
≤ 5.5 hours turnaround time
18 loci (2 panels) - 11 HLA & 7 extended MHC
ABO group
Extended coverage
Balanced reads1
High resolution
Copy number values
1 Hybrid capture enrichment avoids issues related to amplification bias.
The One Lambda HybriType assay offers a streamlined library prep method with fast turnaround time, low bias and minimal artifacts. The workflow may improve laboratory efficiency, with as little as 2.5 hours of hands-on time and next day results.
A streamlined library construction with:
Universal protocol for blood and buccal samples
Single step fragmentation, repair, and adenylation1
Single step barcoding in a user-friendly plate format2
UDI barcodes improve tracking and prevent index hopping
No extra lab equipment needed
1 Provided in a ready-to-use master mix format.
2 No manual mixing of i7 + i5 barcodes is required.
One Lambda HybriType assay offers shorter incubations, easier washes, and faster turnaround time:
Streamlined washing process
Reduced wash steps
Simple to follow
Less technique-sensitive
Incubations at room temperature or in a thermal cycler
18 loci (2 panel) configuration offers greater flexibility in sequencing 11 HLA and 7 extended MHC loci
ABO blood group panel designed to support evolving laboratory requirements
Extended coverage reduces ambiguity and minimizes reflex testing
One Lambda HybriType assay provides coverage across a wide range of loci with the capability to sequence additional genes with a single pipetting step.
Target | Coverage |
---|---|
HLA-A | Full Gene |
HLA-B | Full Gene |
HLA-C | Full Gene |
HLA-DBR1 | Full Exon† |
HLA-DRB345 | Full Exon† |
HLA-DQB1 | Full Gene |
HLA-DQA1 | Full Gene |
HLA-DPB1 | Full Exon† |
HLA-DPA1 | Full Gene |
Target | Coverage |
---|---|
HLA-E | Full Gene |
HLA-F | Full Gene |
HLA-G | Full Gene |
HLA-H | Full Gene |
HLA-J | Full Gene |
MCA | Full Gene |
MICB | Full Exon† |
Target | Coverage |
---|---|
ABO | Full Exon† |
† Average >85% base coverage across intronic regions.
Data for One Lambda HybriType assay is analyzed using our NGS software – TypeStream Visual providing automated and streamlined analysis with a wide range of analytical tools, run statistics and quality metrics.
Copy Number Variation (CNV) tool provides information on the number of copies of each allele per locus. TypeStream Visual analyzes read counts by comparing within and across samples:
The One Lambda HybriType assay is compatible with the Illumina™ platform, including the MiSeq™, MiniSeq™ and iSeq™ instruments.
For Research Use Only. Not for use in diagnostic procedures.